Cuba launches clinic for chikungunya aftereffects

The Institute of Neurology and Neurosurgery in Cuba has begun a specialized clinic to care for patients with post-chikungunya ailments, particularly those linked to neuropathic pain, joint pain, and paresthesia. This step provides focused treatment for individuals impacted by the mosquito-borne virus.

In Havana on December 23, the Institute of Neurology and Neurosurgery in Cuba has launched a specialized clinic dedicated to treating patients with post-chikungunya ailments. The facility focuses on conditions such as neuropathic pain, joint pain, and paresthesia, which are common lingering effects of the mosquito-borne chikungunya virus that causes fever and severe aches.

Chikungunya can lead to long-term complications that impair daily life for those infected. The new clinic aims to address these persistent issues through comprehensive care. As reported by Prensa Latina, this opening meets the demand for specialized health services in Cuba.

While specific patient numbers are not yet available, the clinic is part of Cuba's public health efforts to manage infectious diseases and their neurological aftermaths. This initiative highlights Cuba's dedication to accessible medical treatment for virus-related conditions.

ተያያዥ ጽሁፎች

Comparative illustration of long COVID patients: US woman with severe brain fog and anxiety versus milder symptoms in India, Nigeria, and Colombia, per international study.
በ AI የተሰራ ምስል

International study finds U.S. long COVID patients report more brain fog and psychological symptoms than peers in India and Nigeria

በAI የተዘገበ በ AI የተሰራ ምስል እውነት ተፈትሸ

A Northwestern Medicine-led study of more than 3,100 adults with long COVID found that non-hospitalized participants in the United States reported substantially higher rates of brain fog, depression/anxiety and insomnia than participants in Colombia, Nigeria and India—differences the researchers say likely reflect cultural factors and access to care as much as biology.

Cuban President Miguel Díaz-Canel presented preliminary positive results from clinical trials of the biotechnological drug Jusvinza in patients with chronic post-chikungunya arthritis. The studies, started in December 2025, show notable improvements in provinces like Havana and Matanzas. Experts highlight the drug's safety profile and potential to slow inflammation.

በAI የተዘገበ

Cuba has a favorable epidemiological situation in its fight against arboviruses, following a 21 percent decrease in reported febrile cases last week. This improvement highlights effective efforts to control vector-borne diseases such as dengue and zika. Health authorities emphasize the need for ongoing vigilance.

Kenya's Ministry of Health has warned citizens against non-essential travel to parts of India following confirmation of two Nipah virus cases in West Bengal. The risk of the disease spreading to Kenya remains low, but authorities urge strict personal hygiene for travelers. The World Health Organization has verified the outbreak of this rare but serious illness.

በAI የተዘገበ

In Brazil's shrinking Atlantic Forest, deforestation is causing mosquitoes to increasingly feed on humans, heightening the risk of diseases like dengue and Zika. A new study reveals that out of identified blood meals, most came from people rather than wildlife. This adaptation underscores how habitat loss alters disease transmission patterns.

Researchers from Weill Cornell Medicine and Wake Forest University School of Medicine have identified a stress-response pathway in immune cells that is activated by chemotherapy and leads to painful nerve damage. In mice, blocking this pathway with a drug already in early-stage cancer trials reduced signs of nerve injury, and a small patient study suggests a blood test might one day predict who is most at risk.

በAI የተዘገበ

The Don Benito Health Area has confirmed the death of a 15-year-old teenager from meningoencephalitis caused by reactivation of type 6 virus. The death occurred on March 13 at Vegas Altas hospital. Health authorities state that this variant does not require epidemiological surveillance or specific protocols.

 

 

 

ይህ ድረ-ገጽ ኩኪዎችን ይጠቀማል

የእኛን ጣቢያ ለማሻሻል ለትንታኔ ኩኪዎችን እንጠቀማለን። የእኛን የሚስጥር ፖሊሲ አንብቡ የሚስጥር ፖሊሲ ለተጨማሪ መረጃ።
ውድቅ አድርግ